Literature DB >> 23185211

In vitro antigen-specific induction of IL-22 in human subjects that resolved HCV infection.

Matthew F Cusick1, Jane E Libbey, Robert S Fujinami, David D Eckels.   

Abstract

AIMS: To determine if in vitro production of IL-22 and IL-17 correlated with resolution of HCV infection. MATERIALS #ENTITYSTARTX00026;
METHODS: Human peripheral blood cells isolated from a well-defined cohort of resolved and chronic HCV-infected subjects were used to measure HCV-, influenza- and mitogen-activated T-cell proliferation. In addition, IL-22 and IL-17 production was measured via ELISAs and flow cytometry.
RESULTS: Resolved HCV subjects had a significantly higher T-cell proliferative response to recombinant NS3 protein compared with chronic HCV subjects. Resolved subjects had a dose-dependent IL-22 response to recombinant NS3 compared with chronic HCV subjects.
CONCLUSION: IL-22 production is associated with antigen-specific induction of CD4 (+) T cells in individuals that resolved HCV infection, suggesting a potential role for IL-22 in HCV clearance.

Entities:  

Year:  2012        PMID: 23185211      PMCID: PMC3505095          DOI: 10.2217/fvl.12.58

Source DB:  PubMed          Journal:  Future Virol        ISSN: 1746-0794            Impact factor:   1.831


  50 in total

1.  Immunodominant CD4+ T-cell epitope within nonstructural protein 3 in acute hepatitis C virus infection.

Authors:  H M Diepolder; J T Gerlach; R Zachoval; R M Hoffmann; M C Jung; E A Wierenga; S Scholz; T Santantonio; M Houghton; S Southwood; A Sette; G R Pape
Journal:  J Virol       Date:  1997-08       Impact factor: 5.103

2.  In vivo consequences of liver-specific interleukin-22 expression in mice: Implications for human liver disease progression.

Authors:  Ogyi Park; Hua Wang; Honglei Weng; Lionel Feigenbaum; Hai Li; Shi Yin; Sung Hwan Ki; Seong Ho Yoo; Steven Dooley; Fu-Sheng Wang; Howard A Young; Bin Gao
Journal:  Hepatology       Date:  2011-07       Impact factor: 17.425

Review 3.  Border patrol: regulation of immunity, inflammation and tissue homeostasis at barrier surfaces by IL-22.

Authors:  Gregory F Sonnenberg; Lynette A Fouser; David Artis
Journal:  Nat Immunol       Date:  2011-05       Impact factor: 25.606

4.  Genomic structure and inducible expression of the IL-22 receptor alpha chain in mice.

Authors:  A Tachiiri; R Imamura; Y Wang; M Fukui; M Umemura; T Suda
Journal:  Genes Immun       Date:  2003-03       Impact factor: 2.676

5.  Th22 cells represent a distinct human T cell subset involved in epidermal immunity and remodeling.

Authors:  Stefanie Eyerich; Kilian Eyerich; Davide Pennino; Teresa Carbone; Francesca Nasorri; Sabatino Pallotta; Francesca Cianfarani; Teresa Odorisio; Claudia Traidl-Hoffmann; Heidrun Behrendt; Stephen R Durham; Carsten B Schmidt-Weber; Andrea Cavani
Journal:  J Clin Invest       Date:  2009-11-16       Impact factor: 14.808

6.  Interleukin-17-producing CD4(+) T cells increase with severity of liver damage in patients with chronic hepatitis B.

Authors:  Ji-Yuan Zhang; Zheng Zhang; Fang Lin; Zheng-Sheng Zou; Ruo-Nan Xu; Lei Jin; Jun-Liang Fu; Feng Shi; Ming Shi; Hui-Fen Wang; Fu-Sheng Wang
Journal:  Hepatology       Date:  2010-01       Impact factor: 17.425

7.  Hepatitis C virus induces regulatory T cells by naturally occurring viral variants to suppress T cell responses.

Authors:  Matthew F Cusick; Jennifer J Schiller; Joan C Gill; David D Eckels
Journal:  Clin Dev Immunol       Date:  2010-12-06

8.  Interleukin-17 contributes to the pathogenesis of autoimmune hepatitis through inducing hepatic interleukin-6 expression.

Authors:  Li Zhao; Yanli Tang; Zhengrui You; Qixia Wang; Shuwen Liang; Xiaofeng Han; Dekai Qiu; Jue Wei; Yuan Liu; Lei Shen; Xiaoyu Chen; Yanshen Peng; Zhiping Li; Xiong Ma
Journal:  PLoS One       Date:  2011-04-19       Impact factor: 3.240

9.  Influence of IL-10RA and IL-22 polymorphisms on outcome of hepatitis C virus infection.

Authors:  Branwen J Hennig; Angela J Frodsham; Simon Hellier; Susanne Knapp; Leland J Yee; Mark Wright; Lyna Zhang; Howard C Thomas; Mark Thursz; Adrian V Hill
Journal:  Liver Int       Date:  2007-10       Impact factor: 5.828

10.  Virological footprint of CD4+ T-cell responses during chronic hepatitis C virus infection.

Authors:  Vicki M Fleming; Gillian Harcourt; Eleanor Barnes; Paul Klenerman
Journal:  J Gen Virol       Date:  2010-01-27       Impact factor: 3.891

View more
  1 in total

1.  Pathological Roles of Interleukin-22 in the Development of Recurrent Hepatitis C after Liver Transplantation.

Authors:  Yinjie Gao; Hui Ren; Fanping Meng; Jin Li; Eddie Cheung; Hanwei Li; Jingmin Zhao; Hongling Liu; Zhenwen Liu; Min Zhang
Journal:  PLoS One       Date:  2016-04-28       Impact factor: 3.240

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.